Title card for Your Gut Bacteria Breathe Out Through Your Mouth showing Dr. Padda beside the chapter title text

September 12, 2026

Bloating and constipation · Methane breath test

Bloating and Constipation: The Gas Nobody Measured

by - Dr. Gurpreet Singh Padda, MD, MBA, MHP

Bloating and constipation that never go away often trace back to methane. Methane is a gas made by gut organisms, and only a breath test measures it. Breath methane is tied to constipation at an odds ratio of 3.51. A single fasting reading of 10 ppm or more matches the full two-hour breath test.

She was thirty-three and carried a folder. Inside were three stool reports ordered online over fourteen months, each one contradicting the last. She had also taken four rounds of antimicrobials, each aimed at whatever organism that quarter’s report had named. Nobody had ever measured her breath. When we did, her fasting methane was 19 ppm. The symptom she had called bloating for a decade turned out to be constipation.

Bloating and constipation are what people say when the gut hurts in a way nobody takes seriously. The video Your Gut Bacteria Breathe Out Through Your Mouth, from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, makes the case for measuring. What follows is the practical side for anyone in chronic pain whose belly has been written off as stress. We cover what the breath shows, how often it misleads, and what to ask before another prescription.

What are the symptoms of small bowel bacterial overgrowth?

Bloating sends a workup in one direction. Straining sends it in another. The plan tends to follow the word on the intake form rather than the physiology underneath it, so it is worth asking whether the word you have used for years is the word a physician would use.

The known symptoms of bacterial overgrowth in the small bowel are bloating, diarrhea and belly pain or discomfort. In more severe cases, stools turn fatty. Routine labs can hold a clue too. A high folate paired with a low vitamin B12 is unusual enough to flag on blood work you have already had. In a pain practice, belly discomfort that got folded into a diagnosis of widespread pain deserves that second look. Normal results are exactly what some pain conditions produce.

What does a SIBO breath test measure?

Your own cells make no hydrogen. Every molecule of it in your breath came from microbes fermenting something, crossed the gut wall into the blood and left through the lungs. That makes a breath test a readout of what the gut community is doing today, not a roster of who lives there.

The North American Consensus sets the rules. A hydrogen rise of at least 20 ppm from baseline within 90 minutes counts as positive for overgrowth. A methane level of at least 10 ppm counts as positive. Hydrogen, methane and carbon dioxide have to be measured together. That is because methane-making organisms use up four hydrogen molecules for each methane molecule they build. A heavy methane producer can show a flat hydrogen curve. A lab that reads hydrogen alone will call that patient normal.

The prep is spelled out too: no antibiotics for four weeks before, and a fast of 8 to 12 hours. Despite common instructions, acid reflux pills (proton pump inhibitors) do not need to be stopped first. Long-term acid suppression raises other questions for pain patients.

How accurate is a SIBO breath test?

Not very, and you should hear that before trusting any result. Pooled across case-control studies, 35.5% of people with irritable bowel syndrome (IBS) test positive. So do 29.7% of healthy people. The sugar used skews it further. Compared with glucose, lactulose inflates positive results 3.6-fold in patients and 7.6-fold in healthy people.

Gut layout explains much of the noise. Researchers redid positive glucose tests while a tracer followed the sugar. 48% were false. The colon was fermenting sugar that got there early. After past upper gut surgery, the false rate hit 65%. In the false results, sugar reached the colon in 18 minutes on average. In true overgrowth, it took 79 minutes. That study has its own limits, such as a cutoff for positive that no current test uses.

The order of tests matters too. Take patients with IBS and a positive lactulose test. Their positive fructose tests dropped from 62% to 3% after one week of antibiotics. Nearly every fructose intolerance in that group was bacteria fermenting sugar too early. That is why overgrowth should be ruled out before any lactose or fructose test.

Can methane cause bloating and constipation?

This is where the gas earns its place. Breath methane is tied to constipation at an odds ratio of 3.51. All eight other papers that looked at transit linked methane with slow movement. Methane-heavy overgrowth carries five times the odds of constipation seen with hydrogen-heavy overgrowth.

A single fasting methane of 10 ppm or more matches the full two-hour test at 86.4% sensitivity and 100% specificity. It tracks with the amount of Methanobrevibacter smithii in stool. It holds steady for 14 weeks without treatment and falls within two days of antibiotics. It also tracks how bad symptoms are, though only a bit. Constipation scores were 5.65 in methane-positive people against 4.32 in methane-negative people, a real but small gap.

Does clearing the gas change the symptom? In one randomized trial in constipation-type irritable bowel syndrome, neomycin plus rifaximin gave a severity score of 28.6, against 61.2 on neomycin alone. Inside the combination group, patients whose methane fell below 3 ppm scored 30.5. Those whose methane stayed scored 67.2. Read it with its fine print. Only 31 people were in the main analysis. There was no true placebo group. The entry bar was far below today’s 10 ppm. The split of 15 patients was done after the fact. And follow-up lasted four weeks. It is the best evidence for the mechanism we have, and it is thin. Clearing the weeds is rarely the whole problem.

The flat test, and the dull tests that still matter

Some patients produce a flat line: low, fixed hydrogen and no methane. Hydrogen sulfide can now be measured in breath. In diarrhea-type disease, higher breath sulfide goes with more sulfide-making bacteria such as Fusobacterium and Desulfovibrio. Those links were inferred from a database, not measured. And no consensus body has set a sulfide cutoff. So any lab’s cutoff is the lab’s own.

For a pain patient with belly symptoms, inflammation has to be ruled out early. In adults with IBS symptoms, a C-reactive protein of 0.5 or less, or a stool calprotectin of 40 µg/g or less, leaves a 1% or lower chance of inflammatory bowel disease. That is a strong rule-out. It is not a diagnosis. And calprotectin can’t detect bacterial overgrowth. Pain-sensing nerves and gut inflammation influence each other.

What to do before another round of antibiotics

Her four courses were aimed at four names from reports that commercial laboratories cannot agree on. A stool census cannot tell you what the community is doing; a gas can. Notice which test has a product attached. The kit arrives with colored bars and a reorder button, while a breath test that ends the testing sells nothing further.

The expert guidance in this field admits that the definition of overgrowth is fuzzy. It also admits that treatment after a positive test is mostly trial and error, with real risks from long-term broad antibiotics. That is the case against testing, made by the people who run the tests. My answer: a rough reading of the right thing beats an exact reading of the wrong thing. The alternative on offer is a guess.

So bring questions, not demands. Ask which gases the laboratory measures. Ask whether overgrowth was ruled out before any fructose or lactose test. Ask whether a double peak was used to call you positive, since the consensus no longer accepts it. Note whether the bloating or the straining came first. Do not start, stop or repeat an antibiotic on your own; work it through with your physician. Your sugar cravings run on gut signaling too.

Every figure above, including the math behind the breath test and the full weakness of the methane trials, is in the Angry Gut Deep Dive on breath and biomarker testing. For the patients who do everything right and still don’t improve, the next suspect may be the building itself.

Frequently asked questions

Can SIBO cause bloating and constipation at the same time?

Yes, and methane is the usual link. Methane-heavy overgrowth carries five times the odds of constipation seen with hydrogen-heavy overgrowth. Across the studies that measured it, breath methane is tied to slower transit. One patient called hers bloating for a decade, until a fasting methane of 19 ppm showed constipation. Only a test that measures methane can see it. Gut bacteria shape far more than digestion.

Do I have to stop my acid reflux medication before a breath test?

Under the North American Consensus, acid reflux pills (proton pump inhibitors) do not need to be stopped before breath testing. That goes against the instructions many patients still get. Avoid antibiotics for four weeks before. Fast for 8 to 12 hours, and don’t smoke on the day. The consensus could not agree on probiotics. Any change to your drugs belongs with your physician. Gut bacteria leave measurable traces in the blood as well.

Why did my breath test come back flat?

A flat result, with low fixed hydrogen and no methane, does not always mean a quiet gut. The consensus flags that pattern as a possible hydrogen sulfide producer that standard machines can’t detect. Sulfide is now measurable in breath. Higher levels track with sulfide-making bacteria in diarrhea-type disease. But no consensus body has set a cutoff. Ask exactly which gases your lab measured. The microbiome is being studied as a diagnostic clue in pelvic pain too.

Can a fructose breath test give a false result?

Yes, if bacterial overgrowth was not ruled out first. In patients with IBS who also tested positive on lactulose, positive fructose tests fell from 62% to 3% after a week of antibiotics. Those results showed bacteria fermenting sugar in the small bowel, not a true intolerance. Before you cut fruit out of your diet for years, ask which test was done first. Sugar substitutes carry their own gut effects.

Is a mail-order stool microbiome test worth it for chronic pain?

Rarely as a guide to treatment. When one identical sample went to six commercial services, the diversity verdicts ranged from excellent to unfavorable. No company disclosed the group it compared against. A species list shows who is there, not what they are doing. For belly symptoms, a breath test with all three gases, plus a calprotectin to rule out inflammation, answers more useful questions. The microbiome also shapes mood.

Measure the gas before the next prescription

Has belly discomfort ridden along with your pain for years, with nobody measuring anything? Then we start with the tests that read what your gut is doing. Bring every old report, and we will read them against current criteria.

Request an appointment, or call or text us.

Sources

  1. Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017). Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus. The American Journal of Gastroenterology, 112(5), 775-784. https://doi.org/10.1038/ajg.2017.46
  2. Shah, A., Talley, N. J., Jones, M., Kendall, B. J., Koloski, N., Walker, M. M., Morrison, M., & Holtmann, G. J. (2020). Small intestinal bacterial overgrowth in irritable bowel syndrome: A systematic review and meta-analysis of case-control studies. The American Journal of Gastroenterology, 115(2), 190-201. https://doi.org/10.14309/ajg.0000000000000504
  3. Lin, E. C., & Massey, B. T. (2016). Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clinical Gastroenterology and Hepatology, 14(2), 203-8. https://doi.org/10.1016/j.cgh.2015.07.032
  4. Kunkel, D., Basseri, R. J., Makhani, M. D., Chong, K., Chang, C., & Pimentel, M. (2011). Methane on breath testing is associated with constipation: A systematic review and meta-analysis. Digestive Diseases and Sciences, 56(6), 1612-8. https://doi.org/10.1007/s10620-011-1590-5
  5. Takakura, W., Pimentel, M., Rao, S., Villanueva-Millan, M. J., Chang, C., Morales, W., Sanchez, M., Torosyan, J., Rashid, M., Hosseini, A., Wang, J., Leite, G., Kowalewski, E., Mathur, R., & Rezaie, A. (2022). A single fasting exhaled methane level correlates with fecal methanogen load, clinical symptoms and accurately detects intestinal methanogen overgrowth. The American Journal of Gastroenterology, 117(3), 470-477. https://doi.org/10.14309/ajg.0000000000001607
  6. Pimentel, M., Chang, C., Chua, K. S., Mirocha, J., DiBaise, J., Rao, S., & Amichai, M. (2014). Antibiotic treatment of constipation-predominant irritable bowel syndrome. Digestive Diseases and Sciences, 59(6), 1278-85. https://doi.org/10.1007/s10620-014-3157-8
  7. Villanueva-Millan, M. J., Leite, G., Wang, J., Morales, W., Parodi, G., Pimentel, M. L., Barlow, G. M., Mathur, R., Rezaie, A., Sanchez, M., Ayyad, S., Cohrs, D., Chang, C., Rashid, M., Hosseini, A., Fiorentino, A., Weitsman, S., Chuang, B., Chang, B., … Pimentel, M. (2022). Methanogens and hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes. The American Journal of Gastroenterology, 117(12), 2055-2066. https://doi.org/10.14309/ajg.0000000000001997
  8. Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015). A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. The American Journal of Gastroenterology, 110(3), 444-54. https://doi.org/10.1038/ajg.2015.6
  9. Quigley, E. M. M., Murray, J. A., & Pimentel, M. (2020). AGA Clinical Practice Update on small intestinal bacterial overgrowth: Expert review. Gastroenterology, 159(4), 1526-1532. https://doi.org/10.1053/j.gastro.2020.06.090
  10. Rodriguez, J., Cordaillat-Simmons, M., Badalato, N., Berger, B., Breton, H., de Lahondès, R., Deschasaux-Tanguy, M., Desvignes, C., D’Humières, C., Kampshoff, S., Lavelle, A., Metwaly, A., Quijada, N. M., Seegers, J. F. M. L., Udocor, A., Zwart, H., Maguin, E., Doré, J., & Druart, C. (2024). Microbiome testing in Europe: Navigating analytical, ethical and regulatory challenges. Microbiome, 12(1), 258. https://doi.org/10.1186/s40168-024-01991-x

Dr. Gurpreet Singh Padda, MD, MBA, MHP

Schedule An Appointment

We’d be happy to answer any questions you have via email, or you can give us a call for a quick response.

Recent Blogs